Researchers Develop CRISPR-Based Test for Rapid Leukemia Diagnosis
Researchers have developed a CRISPR-based diagnostic test that accurately detects gene fusions in APL and CML within two hours.
Read MorePosted by Andy Lundin | Oct 9, 2024 | Leukemia |
Researchers have developed a CRISPR-based diagnostic test that accurately detects gene fusions in APL and CML within two hours.
Read MorePosted by Andy Lundin | Jan 9, 2024 | Leukemia |
An AI-based solution may help predict various genetic features based on microscopic images of bone marrow smears to improve AML diagnosis.
Read MorePosted by Andy Lundin | Nov 13, 2023 | Leukemia |
A novel assay that identifies a unique molecular marker in acute myeloid leukemia patients may revolutionize how the disease is detected.
Read MorePosted by Andy Lundin | Oct 25, 2023 | Leukemia |
Alercell’s leukemia test will use terminal erythroid differentiation for prognostic classification in patients with myeloid malignancies.
Read MorePosted by Melanie Hamilton-Basich | Apr 24, 2023 | Molecular Diagnostics |
The LENA Molecular Dx Leukemia Platform is a core group of 12 molecular diagnostic tests that can be processed on a standard qPCR machine.
Read More